Godavari Drugs Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 442.8 million compared to INR 329.58 million a year ago. Revenue was INR 443.96 million compared to INR 330.72 million a year ago. Net income was INR 12.68 million compared to INR 12.86 million a year ago. Basic earnings per share from continuing operations was INR 1.68 compared to INR 1.71 a year ago. Diluted earnings per share from continuing operations was INR 1.68 compared to INR 1.71 a year ago.